Xinhua
23 Jun 2022, 19:25 GMT+10
KIGALI, June 23 (Xinhua) -- BioNTech, a leading biotechnology company on Thursday laid a foundation stone for the construction of the first manufacturing site for mRNA-based vaccines in Africa, expected to address the issue of vaccine equity.
The facility in Rwanda's capital city Kigali will be based on BioNTainer concept-- exact replications of the BioNTech factory in Marburg, Germany, according to Ugur Sahin, the chief executive officer and co-founder of BioNTech.
At an event in Rwanda's Special Economic Zone in Kigali, Sahin described the groundbreaking ceremony as a milestone in the setting up of scalable mRNA vaccine production in Africa.
The company expects to set up additional factories in Senegal and South Africa in close coordination with its partners in the respective countries.
"We have reached the next milestone with the construction start of the first African mRNA manufacturing facility based on our BioNTainers - just four months after we introduced the BioNTainer concept in February," he said.
"This factory will be the first in an African network to provide sustainable production capacity for mRNA pharmaceuticals. Further manufacturing facilities in Africa and on other continents are planned to follow. The goal we pursue together with governments and regulatory authorities is to produce vaccines for Africa here with highly skilled professionals from Africa," he added.
The company's program aims to develop a highly effective malaria vaccine based on BioNTech's mRNA platform with the vaccine candidates expected to enter first-in-human trials later in 2022, according to Sahin.
"The COVID-19 pandemic exposed the need for significantly greater local production of vaccines and other essential products in all regions of the world, especially in Africa which relies heavily on imported products and was left behind in the global rush for COVID-19 vaccines," said Dr Tedros Adhanom Ghebreyesus, the World Health Organization (WHO) Director-General.
"I welcome BioNTech's efforts to establish manufacturing sites in Rwanda, Senegal and South Africa, as well as its plans to commence clinical trials of its malaria vaccine candidates later this year," he said.
Rwandan President Paul Kagame said, by working with other partners, Rwanda would build on the investment to attract a vibrant biopharmaceutical research and manufacturing sector.
"We are happy to have BioNTech as a partner, and I applaud the company's commitment to working with Africa on a continental basis to help secure our vaccine resilience for the future and invest in new research to address the endemic diseases that disproportionately affect our people," he said.
Ursula von der Leyen, President of the European Commission in a video message said the 'Vaccine Equity for Africa' project represents the immense potential of African and European cooperation.
"Our partnership will bring vaccine manufacturing in Africa to the next level," she said.
In a statement, BioNTech indicated it will work with staff from its sites in Germany to accelerate the training of about 100 colleagues who will be running the production and all associated laboratory and quality assurance tasks on the Africa site.
The BioNTainers will be equipped to manufacture a range of mRNA-based vaccines targeted to the needs of the African Union member states, which could conceivably include the Pfizer-BioNTech COVID-19 vaccine and BioNTech's investigational malaria and tuberculosis vaccines, once they are successfully developed, approved or authorized by regulatory authorities, according to the statement.
"The estimated initial annual capacity of the Pfizer-BioNTech COVID-19 vaccine will be about 50 million doses. Manufacturing in the BioNTainers in Rwanda is expected to commence approximately 12 to 18 months after their installation," it said.
Get a daily dose of Europe Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Europe Sun.
More InformationMADRID, Spain: Liverpool footballer Diogo Jota and his younger brother, André Silva, have died in a car accident in Spain. Spanish...
LONDON, U.K.: An unrelenting heatwave sweeping across Europe has pushed early summer temperatures to historic highs, triggering deadly...
President Donald Trump's plans to build a space-based Golden Dome missile defense shield have drawn immediate criticism from China,...
NEW YORK CITY, New York: Paramount has agreed to pay US$16 million to settle a lawsuit brought by U.S. President Donald Trump over...
LONDON, U.K.: British Prime Minister Keir Starmer won a vote in Parliament this week to move ahead with changes to the country's welfare...
WASHINGTON, D.C.: President Donald Trump will meet Israeli Prime Minister Benjamin Netanyahu at the White House on Monday. President...
FRANKLIN, Tennessee: Hundreds of thousands of Nissan and Infiniti vehicles are being recalled across the United States due to a potential...
REDMOND, Washington: Microsoft is the latest tech giant to announce significant job cuts, as the financial strain of building next-generation...
LONDON UK - U.S. stock markets were closed on Friday for Independence Day. Global Forex Markets Wrap Up Friday with Greeback Comeback...
SANTA CLARA, California: Nvidia came within a whisker of making financial history on July 3, briefly surpassing Apple's all-time market...
SACRAMENTO, California: California's multibillion-dollar farms are facing a growing crisis—not from drought or pests, but from a sudden...
WASHINGTON, D.C.: President Donald Trump says the United States could soon reach a trade deal with India. He believes this deal would...